Matches in Wikidata for { <http://www.wikidata.org/entity/Q98603660> ?p ?o ?g. }
Showing items 1 to 43 of
43
with 100 items per page.
- Q98603660 description "clinical trial" @default.
- Q98603660 description "ensayo clínico" @default.
- Q98603660 description "ensayu clínicu" @default.
- Q98603660 description "klinisch onderzoek" @default.
- Q98603660 description "клінічне випробування" @default.
- Q98603660 description "临床试验" @default.
- Q98603660 name "An Efficacy Study of Secukinumab in Plaque Psoriasis Patients With Subclinical Psoriatic Arthritis as Measured by Musculoskeletal Ultrasound" @default.
- Q98603660 name "An Efficacy Study of Secukinumab in Plaque Psoriasis Patients With Subclinical Psoriatic Arthritis as Measured by Musculoskeletal Ultrasound" @default.
- Q98603660 type Item @default.
- Q98603660 label "An Efficacy Study of Secukinumab in Plaque Psoriasis Patients With Subclinical Psoriatic Arthritis as Measured by Musculoskeletal Ultrasound" @default.
- Q98603660 label "An Efficacy Study of Secukinumab in Plaque Psoriasis Patients With Subclinical Psoriatic Arthritis as Measured by Musculoskeletal Ultrasound" @default.
- Q98603660 prefLabel "An Efficacy Study of Secukinumab in Plaque Psoriasis Patients With Subclinical Psoriatic Arthritis as Measured by Musculoskeletal Ultrasound" @default.
- Q98603660 prefLabel "An Efficacy Study of Secukinumab in Plaque Psoriasis Patients With Subclinical Psoriatic Arthritis as Measured by Musculoskeletal Ultrasound" @default.
- Q98603660 P1050 Q98603660-A7F1A609-460F-4005-8C37-C6D1298E48A1 @default.
- Q98603660 P1132 Q98603660-7281214B-065C-4573-878B-685D344082F9 @default.
- Q98603660 P1476 Q98603660-61AD4985-E293-4EE3-84A4-7EC3EE648488 @default.
- Q98603660 P1813 Q98603660-16D5EDCA-5091-41A9-B7ED-F0CC8D4AB4F3 @default.
- Q98603660 P2899 Q98603660-E4107BF4-16C6-428B-B52C-768FB5F100DA @default.
- Q98603660 P3098 Q98603660-35E9CD91-DE22-4853-B539-7583CF1A70E6 @default.
- Q98603660 P31 Q98603660-54C8277D-EFCB-46C2-A0FA-D20214BE9960 @default.
- Q98603660 P580 Q98603660-B9B33559-75EA-466E-9137-94398E956E46 @default.
- Q98603660 P582 Q98603660-B3D3E663-CE3E-4BA6-958B-71777C0443A7 @default.
- Q98603660 P6099 Q98603660-026DA643-6A21-4F9E-9164-1CF291BA73BC @default.
- Q98603660 P8005 Q98603660-D20FEA37-3B1C-43AC-AFB2-0D947817D418 @default.
- Q98603660 P8363 Q98603660-081BBC3F-7A9F-492E-BC51-4E05D7E7D7BC @default.
- Q98603660 P859 Q98603660-C9F83EF1-F9AD-418A-8655-ABAA031CC5D8 @default.
- Q98603660 P921 Q98603660-174D7336-EABF-4C07-A6A6-77821F1C8FE0 @default.
- Q98603660 P921 Q98603660-A3A9E7AD-109C-49DF-B662-B79820D415CD @default.
- Q98603660 P1050 Q179945 @default.
- Q98603660 P1132 "+75" @default.
- Q98603660 P1476 "An Exploratory, Randomized, Double-blind, Parallel-group, Multicenter Study to Compare Secukinumab 300 mg With Placebo After 16 Weeks of Treatment in Adults With Moderate to Severe Plaque Psoriasis and Subclinical Enthesitis Measured by Musculoskeletal Ultrasound" @default.
- Q98603660 P1813 "INTERCEPT" @default.
- Q98603660 P2899 "+18" @default.
- Q98603660 P3098 "NCT04488185" @default.
- Q98603660 P31 Q30612 @default.
- Q98603660 P580 "2020-09-30T00:00:00Z" @default.
- Q98603660 P582 "2022-02-17T00:00:00Z" @default.
- Q98603660 P6099 Q42825046 @default.
- Q98603660 P8005 Q76649614 @default.
- Q98603660 P8363 Q78089383 @default.
- Q98603660 P859 Q507154 @default.
- Q98603660 P921 Q179945 @default.
- Q98603660 P921 Q58119155 @default.